Skip to main content
. 2004 May 25;91(1):84–91. doi: 10.1038/sj.bjc.6601884

Figure 3.

Figure 3

Incremental costs and life years gained of different options in comparison to the baseline option of 3-year screening with repeat cytology following mild or borderline smear results and no LBC. Costs and life years are discounted at 3.5% per annum. The areas represent the range of outcomes from all possible combinations of alternative assumptions used in the sensitivity analysis, except discounting.